Reduced fluence corneal cross-linking in mild to moderate keratoconus: One year-follow-up.

Seyed Reza GhaffariSaeed KhaheshiFateme AlipourSomayye Mashhadi FarahaniAmir-Hooshang BeheshtnejadFarhad Hafezi

Published in: European journal of ophthalmology (2020)

The results of this study show comparable one-year outcomes between 3.8 and 5.4 J/cm2 accelerated CXL in mild to moderate keratoconus. Should the results of this study be confirmed in longer follow-ups, using a reduced fluence setting could be considered as an alternative to standard treatment in these patients.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
type diabetes
skeletal muscle
patient reported outcomes
replacement therapy
wound healing
combination therapy